Ibrahim Cagri Turker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ibrahim Cagri Turker has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Ceylan Uslu Doğan
Department of Ophthalmology, Sisli Hamidiye Etfal Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
9 shared publications - Sümeyra Keleş Yeşiltaş
Department of Ophthalmology, Sisli Hamidiye Etfal Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
3 shared publications - Abdurrahman Alpaslan Alkan
Department of Ophthalmology, Erciş Şehit Rıdvan Çevik State Hospital, Van, Turkey
2 shared publications - Ayşe Burcu Dirim
UNIVERSITY OF HEALTH SCIENCES, ANKARA KEÇİÖREN EDUCATION AND RESEARCH HOSPITAL
2 shared publications Ceylan Uslu Dogan
Univ Hlth Sci Turkey, Sisli Hamidiye Etfal Training & Res Hosp, Dept Ophthalmol, Istanbul, Turkey
2 shared publicationsDilek Guven
Department of Ophthalmology, Sisli Hamidiye Etfal Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
2 shared publications
Latest Publications
- 18 November 2026
- Published by Taylor & Francis in Current Eye Research
- p. 1-9
OCTA Assessment of Retinal Vascular Reactivity to Breath-Holding in Type 2 Diabetes Mellitus
- 18 November 2026
- Published by Taylor & Francis in Current Eye Research
- p. 1-9
OCTA Assessment of Retinal Vascular Reactivity to Breath-Holding in Type 2 Diabetes Mellitus
- 16 February 2023
- Published by Galenos Yayinevi in Hamidiye Medical Journal
- Vol. 4 (1) , 56-62
Ocular and Imaging Findings in Bardet-Biedl Syndrome with Advanced Stage Retinal Dystrophy
- 16 February 2023
- Published by Galenos Yayinevi in Hamidiye Medical Journal
- Vol. 4 (1) , 56-62
Ocular and Imaging Findings in Bardet-Biedl Syndrome with Advanced Stage Retinal Dystrophy
- 14 December 2022
- Published by Springer Nature in International Ophthalmology
- Vol. 43 (7) , 2161-2169
Topical cyclosporine versus allergen specific immunotherapy in perennial allergic conjunctivitis
Purpose Symptom control in the long-term with less side effects is important in perennial allergic conjunctivitis, since would improve quality of life. This study aimed to assess the clinical efficacies of topical cyclosporin A and subcutaneous allergen immunotherapy (SCIT) in terms of sign control in perennial allergic conjunctivitis. Methods This retrospective study included 20 adult patients with perennial allergic conjunctivitis and confirmed sensitization to house dust mites with skin prick test. Patients were assigned to either topical cyclosporine A treatment or SCIT. The participants were followed for 6 months, and signs scores were recorded at 1, 3 and 6 months. Results Overall, both cyclosporine and immunotherapy groups showed significant improvements in papillary reaction (p = 0.011 and 0.003, respectively), limbal involvement (p = 0.031 and 0.001), and conjunctival hyperemia (p = 0.001 and p < 0.001) scores during the 6-month follow-up. However, only cyclosporine group showed a significant improvement in corneal involvement scores (p = 0.015) during the study period. When scores at different time points were compared, significant improvement in conjunctival hyperemia was evident at 6 months in both groups when compared to baseline (cyclosporine group, 0.7 ± 0.68 vs. 2.4 ± 0.84, 70.8% decrease, p = 0.01; immunotherapy group, 0.3 ± 0.48 vs. 2.3 ± 0.95, 87.0% decrease, p = 0.004), whereas for limbal involvement such an improvement was only evident in the immunotherapy group (0.1 ± 0.32 vs. 1.3 ± 0.95, 92.3% decrease, p = 0.01). Conclusions Allergen immunotherapy and cyclosporin A treatment may provide effective sign relief in perennial allergic conjunctivitis. It may represent an encouraging treatment option particularly for cases with perennial allergic conjunctivitis refractive to other treatments and positive skin prick test to a specific allergen (house dust in the present study). Long-term relief by SCIT would reduce the side effects of polypharmacotherapy. Larger studies with longer follow-up are warranted to confirm our findings.
- 14 December 2022
- Published by Springer Nature in International Ophthalmology
- Vol. 43 (7) , 2161-2169
Topical cyclosporine versus allergen specific immunotherapy in perennial allergic conjunctivitis
Purpose Symptom control in the long-term with less side effects is important in perennial allergic conjunctivitis, since would improve quality of life. This study aimed to assess the clinical efficacies of topical cyclosporin A and subcutaneous allergen immunotherapy (SCIT) in terms of sign control in perennial allergic conjunctivitis. Methods This retrospective study included 20 adult patients with perennial allergic conjunctivitis and confirmed sensitization to house dust mites with skin prick test. Patients were assigned to either topical cyclosporine A treatment or SCIT. The participants were followed for 6 months, and signs scores were recorded at 1, 3 and 6 months. Results Overall, both cyclosporine and immunotherapy groups showed significant improvements in papillary reaction (p = 0.011 and 0.003, respectively), limbal involvement (p = 0.031 and 0.001), and conjunctival hyperemia (p = 0.001 and p < 0.001) scores during the 6-month follow-up. However, only cyclosporine group showed a significant improvement in corneal involvement scores (p = 0.015) during the study period. When scores at different time points were compared, significant improvement in conjunctival hyperemia was evident at 6 months in both groups when compared to baseline (cyclosporine group, 0.7 ± 0.68 vs. 2.4 ± 0.84, 70.8% decrease, p = 0.01; immunotherapy group, 0.3 ± 0.48 vs. 2.3 ± 0.95, 87.0% decrease, p = 0.004), whereas for limbal involvement such an improvement was only evident in the immunotherapy group (0.1 ± 0.32 vs. 1.3 ± 0.95, 92.3% decrease, p = 0.01). Conclusions Allergen immunotherapy and cyclosporin A treatment may provide effective sign relief in perennial allergic conjunctivitis. It may represent an encouraging treatment option particularly for cases with perennial allergic conjunctivitis refractive to other treatments and positive skin prick test to a specific allergen (house dust in the present study). Long-term relief by SCIT would reduce the side effects of polypharmacotherapy. Larger studies with longer follow-up are warranted to confirm our findings.
- 1 August 2022
- Published by Elsevier in Canadian Journal of Ophthalmology
- Vol. 57 (4) , 236-241
Evaluation of early and late COVID-19-induced vascular changes with OCTA
- 1 August 2022
- Published by Elsevier in Canadian Journal of Ophthalmology
- Vol. 57 (4) , 236-241
Evaluation of early and late COVID-19-induced vascular changes with OCTA
- Open Access
- 7 July 2022
- Published by Wiley in Journal of Ophthalmology
- Vol. 2022, 1-5
Success Rate Comparis on of External Dacryocystorhinostomy with 5-FU Application or Silicone Tube Intubation
Aims. To compare anatomical and functional success rates in patients with primary acquired nasolacrimal duct obstruction undergoing external dacryocystorhinostomy (EX-DCR) either with adjunctive 5-fluorouracil (5-FU) or silicone tube intubation. Methods. In this retrospective comparative study, 37 eyes in 32 patients who underwent EX-DCR with adjunctive 5-FU (5-FU group) and 43 eyes in 40 patients who underwent EX-DCR with silicone intubation (controls) between 2018 and 2019 were included. Results. The mean age of patients in 5-FU and control groups was 59.8 ± 9.4 and 57.0 ± 15.3 years, respectively. The mean follow-up was 18.70 ± 3.47 months in the 5-FU group and 21.38 ± 7.76 months in the control group. Anatomical success was determined based on patency rates at the time of irrigation and recurrence, while subjective symptoms (improvement in tearing) were used to evaluate the functional success. Lacrimal patency rates in 5-FU and control groups were 83.3% and 86.0%, respectively, while recurrence was observed in 16.2% of 5-FU and 14.0% of control subjects. The two groups were comparable in terms of patency and recurrence rates ( ) as well as rates of epiphora ( ). Conclusion. Both EX-DCR procedures were effective in the management of nasolacrimal duct obstruction. Our results suggest that EX-DCR augmented with 5-FU may represent a more feasible and cost-effective therapeutic option as compared to silicone tube placement in these patients.
- 7 July 2022
- Published by Wiley in Journal of Ophthalmology
- Vol. 2022, 1-5
Open AccessSuccess Rate Comparis on of External Dacryocystorhinostomy with 5-FU Application or Silicone Tube Intubation
Aims. To compare anatomical and functional success rates in patients with primary acquired nasolacrimal duct obstruction undergoing external dacryocystorhinostomy (EX-DCR) either with adjunctive 5-fluorouracil (5-FU) or silicone tube intubation. Methods. In this retrospective comparative study, 37 eyes in 32 patients who underwent EX-DCR with adjunctive 5-FU (5-FU group) and 43 eyes in 40 patients who underwent EX-DCR with silicone intubation (controls) between 2018 and 2019 were included. Results. The mean age of patients in 5-FU and control groups was 59.8 ± 9.4 and 57.0 ± 15.3 years, respectively. The mean follow-up was 18.70 ± 3.47 months in the 5-FU group and 21.38 ± 7.76 months in the control group. Anatomical success was determined based on patency rates at the time of irrigation and recurrence, while subjective symptoms (improvement in tearing) were used to evaluate the functional success. Lacrimal patency rates in 5-FU and control groups were 83.3% and 86.0%, respectively, while recurrence was observed in 16.2% of 5-FU and 14.0% of control subjects. The two groups were comparable in terms of patency and recurrence rates ( ) as well as rates of epiphora ( ). Conclusion. Both EX-DCR procedures were effective in the management of nasolacrimal duct obstruction. Our results suggest that EX-DCR augmented with 5-FU may represent a more feasible and cost-effective therapeutic option as compared to silicone tube placement in these patients.
- Open Access
- 28 June 2022
- Published by Kare Publishing in SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital
- Vol. 56 (2) , 196-201
Evaluation of Peripapillary and Macular Vascular Flow Changes with OCT-A in Patients with Superficial Optic Disc Drusen
The Medical Bulletin of Sisli Etfal Hospital
- 28 June 2022
- Published by Kare Publishing in SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital
- Vol. 56 (2) , 196-201
Open AccessEvaluation of Peripapillary and Macular Vascular Flow Changes with OCT-A in Patients with Superficial Optic Disc Drusen
The Medical Bulletin of Sisli Etfal Hospital
- 28 September 2021
- Published by Galenos Yayinevi in Medical Journal of Bakırkoy
- Vol. 17 (3) , 179-183
Comparing Surgical Results of Lower Eyelid Retractor Advancement and Retractor Advancement with Lateral Tarsal Strip for Involutional Entropion
- 28 September 2021
- Published by Galenos Yayinevi in Medical Journal of Bakırkoy
- Vol. 17 (3) , 179-183
Comparing Surgical Results of Lower Eyelid Retractor Advancement and Retractor Advancement with Lateral Tarsal Strip for Involutional Entropion
- 19 September 2021
- Published by Taylor & Francis in Clinical and Experimental Optometry
- Vol. 105 (7) , 740-745
Optical coherence tomography findings and choroidal neovascular membrane detectability with optical coherence tomography angiography in different subtypes of pattern dystrophy
Optical coherence tomography angiography (OCTA) is a useful method for determining choroidal neovascular membranes (CNVM) in different subtypes of pattern dystrophy.We aimed to evaluate the optical...
- 19 September 2021
- Published by Taylor & Francis in Clinical and Experimental Optometry
- Vol. 105 (7) , 740-745
Optical coherence tomography findings and choroidal neovascular membrane detectability with optical coherence tomography angiography in different subtypes of pattern dystrophy
Optical coherence tomography angiography (OCTA) is a useful method for determining choroidal neovascular membranes (CNVM) in different subtypes of pattern dystrophy.We aimed to evaluate the optical...
- 1 April 2021
- Published by Elsevier in Canadian Journal of Ophthalmology
- Vol. 56 (2) , 83-87
Optical coherence tomography angiography findings in patients with COVID-19
- 1 April 2021
- Published by Elsevier in Canadian Journal of Ophthalmology
- Vol. 56 (2) , 83-87
Optical coherence tomography angiography findings in patients with COVID-19
- 18 January 2021
- Published by Springer Nature in International Ophthalmology
- Vol. 41 (4) , 1337-1345
Peripapillary vessel density in pediatric cases with buried optic disk drusen
Background To evaluate the retinal nerve fiber layer (RNFL) and peripapillary vascular density (VD) changes in the pediatric group with optic disk drusen (ODD). Methods Sixty eyes of 30 patients with buried ODD referred by the pediatric or neurology physicians to ophthalmology clinic with a preliminary diagnosis of papillary edema were included in this retrospective study. Sixty eyes of 30 healthy children were included as the control group. Thickness of RNFL (micrometer) and VD percentages (%) of the superior, inferior, nasal, and temporal quadrants of the peripapillary region of all cases were evaluated with optical coherence tomography angiography (OCT-A) device. Results The study and control groups were homogeneous in terms of age and gender. VD values were significantly lower in the study group for all four quadrants, when compared to controls (p < 0.001, p < 0.001, p = 0.003, and p < 0.001, for inferior, superior, nasal, and temporal quadrants, respectively. For RFNL thickness measurements, a significant difference between groups was only evident for the nasal quadrant, where the study group had significantly higher nasal RFNL thickness (p = 0.001). Conclusion This study detected decreases in peripapillary VD values in all quadrants and peripapillary RNFL thickening in nasal quadrant in pediatric cases with buried drusen compared to healthy controls. Further studies are necessary to reveal the effects of drusen pathogenesis on optic nerve head perfusion and to understand the underlying mechanisms of related complications.
- 18 January 2021
- Published by Springer Nature in International Ophthalmology
- Vol. 41 (4) , 1337-1345
Peripapillary vessel density in pediatric cases with buried optic disk drusen
Background To evaluate the retinal nerve fiber layer (RNFL) and peripapillary vascular density (VD) changes in the pediatric group with optic disk drusen (ODD). Methods Sixty eyes of 30 patients with buried ODD referred by the pediatric or neurology physicians to ophthalmology clinic with a preliminary diagnosis of papillary edema were included in this retrospective study. Sixty eyes of 30 healthy children were included as the control group. Thickness of RNFL (micrometer) and VD percentages (%) of the superior, inferior, nasal, and temporal quadrants of the peripapillary region of all cases were evaluated with optical coherence tomography angiography (OCT-A) device. Results The study and control groups were homogeneous in terms of age and gender. VD values were significantly lower in the study group for all four quadrants, when compared to controls (p < 0.001, p < 0.001, p = 0.003, and p < 0.001, for inferior, superior, nasal, and temporal quadrants, respectively. For RFNL thickness measurements, a significant difference between groups was only evident for the nasal quadrant, where the study group had significantly higher nasal RFNL thickness (p = 0.001). Conclusion This study detected decreases in peripapillary VD values in all quadrants and peripapillary RNFL thickening in nasal quadrant in pediatric cases with buried drusen compared to healthy controls. Further studies are necessary to reveal the effects of drusen pathogenesis on optic nerve head perfusion and to understand the underlying mechanisms of related complications.